We are EDENT1FI We aim to identify early Type 1 Diabetes in children.
We are dedicated to implement a general population autoantibody screening for early-stage Type 1 Diabetes (T1D) in 200,000 children across Europe. Our mission encompasses not only the early detection of T1D in children but also the provision of continuous support and education to families navigating this challenge. By equipping these families with essential knowledge and resources, our aim is to empower them to effectively manage T1D. Through our comprehensive efforts we aspire to positively impact the lives of affected families, fostering understanding and proactive care.
Do you want to know more about local initiatives?
Click here!
About Type 1
Diabetes
Type 1 diabetes is a chronic condition where the immune system attacks the insulin-producing cells in the pancreas, leading to high blood sugar levels. It requires insulin management through injections or pumps for proper control. T1D typically begins in children and adolescents and affects approximately 9 million people worldwide, making it the most common metabolic disorder in children.
